30, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces four oral presentations and two posters on analyses from its successful Phase 3 ...

In this article, we are going to take a look at where Verona Pharma plc (NASDAQ:VRNA) stands against the other best ...

Kathleen A. Rickard, the Chief Medical Officer of $VRNA, sold 79,264 shares of the company on 03-12-2025 for an estimated $661,941. We received data on the trade from ...

Does MP behave like a motor MAP, transporting itself and vRNA as a complex along the microtubule? Does it remain stationary, moving RNA relative to itself? If MP remains tightly bound, are ...

Verona Pharma plc (VRNA) is not on our list of the 30 Most Popular Stocks Among Hedge Funds.As per our database, 42 hedge ...

1 Day VRNA -7.21% DJIA -5.50% S&P 500 -5.97% Health Care/Life Sciences 4.56% ...

Shares of VRNA stock opened at $67.50 on Friday. The company has a debt-to-equity ratio of 0.93, a current ratio of 13.03 and a quick ratio of 12.88. Verona Pharma has a fifty-two week low of $11. ...

In this article, we are going to take a look at where Verona Pharma plc (NASDAQ:VRNA) stands against other stocks that Jim Cramer discussed recently. Jim Cramer, host of Mad Money, expressed his ...

Shares of VRNA stock opened at $64.18 on Thursday. The company has a debt-to-equity ratio of 0.93, a quick ratio of 12.88 and a current ratio of 13.03. The firm has a market cap of $5.19 billion ...